In the early stages of tumor development (before 16 days in 4T1 and 22 days in E0771 models), CD8+ T cells were more dominant than CD4+ T cells in TILs; while the reversed proportion was observed in the late stages of tumor development. The gene discussed is CD4; the disease is neoplasm.